Cytotoxic T lymphocyte antigen-4 (CTLA-4) gene polymorphisms and susceptibility to type 1 autoimmune hepatitis (Q56906375)

https://api.crossref.org/works/10.1002%2FHEP.510310110

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310110

7 January 2021

Chronic active hepatitis associated with antiliver/kidney microsome antibody type 1: a second type of "autoimmune" hepatitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310110

7 January 2021

Susceptibility to autoimmune chronic active hepatitis: human leukocyte antigens DR4 and A1-B8-DR3 are independent risk factors

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310110

7 January 2021

Associations between alleles of the major histocompatibility complex and type 1 autoimmune hepatitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310110

7 January 2021

Allelic sequence variation in the HLA class II genes and proteins in patients with autoimmune hepatitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310110

7 January 2021

Allelic basis for HLA-encoded susceptibility to type 1 autoimmune hepatitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310110

7 January 2021

T-cell receptor constant beta germline gene polymorphisms and susceptibility to autoimmune hepatitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310110

7 January 2021

Limited T cell receptor Vbeta-chain repertoire of liver-infiltrating T cells in autoimmune hepatitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310110

7 January 2021

Frequency and nature of cytokine gene polymorphisms in type 1 autoimmune hepatitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310110

7 January 2021

Cytokine polymorphisms associated with clinical features and treatment outcome in type 1 autoimmune hepatitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310110

7 January 2021

T-cell-directed hepatocyte damage in autoimmune chronic active hepatitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310110

7 January 2021

Clonal analysis of liver-infiltrating T cells in patients with LKM-1 antibody-positive autoimmune chronic active hepatitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310110

7 January 2021

The emerging role of CTLA-4 as an immune attenuator

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310110

7 January 2021

Insulin-dependent diabetes mellitus (IDDM) is associated with CTLA4 polymorphisms in multiple ethnic groups

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310110

7 January 2021

Meeting report: International Autoimmune Hepatitis Group

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310110

7 January 2021

Frequency and significance of antibodies to actin in type 1 autoimmune hepatitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310110

7 January 2021

Patterns of nuclear immunofluorescence and reactivities to recombinant nuclear antigens in autoimmune hepatitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310110

7 January 2021

Antinuclear antibodies and patterns of nuclear immunofluorescence in type 1 autoimmune hepatitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310110

7 January 2021

Frequency and significance of antibodies to liver/kidney microsome type 1 in adults with chronic active hepatitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310110

7 January 2021

A stable sheep cell preparation for detecing thyroglobulin auto-antibodies and its clinical applications

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310110

7 January 2021

PRIMARY HYPERPARATHYROIDISM: A CRITICAL REVIEW.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310110

7 January 2021

Evaluation of a tanned red cell technique for thyroid microsomal antibodies

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310110

7 January 2021

Sensitivity, specificity, and predictability of biopsy interpretations in chronic hepatitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310110

7 January 2021

The role of CTLA-4 in the regulation of T cell immune responses.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310110

7 January 2021

Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310110

7 January 2021

Cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) regulates the unfolding of autoimmune diabetes

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310110

7 January 2021

Induction of peripheral T cell tolerance in vivo requires CTLA-4 engagement.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310110

7 January 2021

Phenotypical analysis and cytokine release of liver-infiltrating and peripheral blood T lymphocytes from patients with chronic hepatitis of different etiology

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310110

7 January 2021

A conserved AU sequence from the 3' untranslated region of GM-CSF mRNA mediates selective mRNA degradation

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310110

7 January 2021

The CTLA-4 gene region of chromosome 2q33 is linked to, and associated with, type 1 diabetes. Belgian Diabetes Registry

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310110

7 January 2021

Significance of HLA DR4 in type 1 autoimmune hepatitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310110

7 January 2021

Clustering of non-major histocompatibility complex susceptibility candidate loci in human autoimmune diseases

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310110

7 January 2021

Comparative genetics of type 1 diabetes and autoimmune disease: common loci, common pathways?

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310110

7 January 2021